The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

• Main Authors: Ziwen Wang (Author), Shanshan Li (Author), Ruifeng Wang (Author), Liansheng Guo (Author), Dan Xu (Author), Tieyuan Zhang (Author), Yifan Xu (Author), Wenlong Wang (Author), Min Wang (Author), Zhongwei Gan (Author), Xiaobing Wang (Author)
• Format: Book
• Published: BMC, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Our objective was to investigate the efficacy of the beta-3 adrenergic receptor (β3-AR) agonist BRL37344 for the prevention of liver steatosis and inflammation associated with nonalcoholic fatty liver disease (NAFLD). Methods Four groups were established: a control group (given a...